Fadhil, H.R. et al. 2023. Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#. Iraqi Journal of Pharmaceutical Sciences. 31, Suppl. (Feb. 2023), 100–110. DOI:https://doi.org/10.31351/vol31issSuppl.pp100-110.